Sintx Technologies (SINT) Return on Capital Employed Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 9,412.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,412.00 |
| Dec 31, 2025 | 13,524.00 |
| Sep 30, 2025 | -3,680.00 |
| Jun 30, 2025 | -7,022.00 |
| Mar 31, 2025 | -5,595.00 |
| Dec 31, 2024 | -6,112.00 |
| Sep 30, 2024 | -3,412.00 |
| Jun 30, 2024 | -1,642.00 |
| Mar 31, 2024 | -1,974.00 |
| Dec 31, 2023 | 5,331.00 |
| Sep 30, 2023 | -1,595.00 |
| Jun 30, 2023 | -207.00 |
| Mar 31, 2023 | -2,504.00 |
| Dec 31, 2022 | -10,837.00 |
| Sep 30, 2022 | -3,831.00 |
| Jun 30, 2022 | -3,231.00 |
| Mar 31, 2022 | -2,424.00 |
| Dec 31, 2021 | -2,186.00 |
| Sep 30, 2021 | -1,434.00 |
| Jun 30, 2021 | 296.00 |
| Mar 31, 2021 | 3,190.00 |
| Dec 31, 2020 | 5,478.00 |
| Sep 30, 2020 | -8,424.00 |
| Jun 30, 2020 | -3,228.00 |
| Mar 31, 2020 | -5,115.00 |
| Dec 31, 2019 | -6,702.00 |
| Sep 30, 2019 | 12,339.00 |
| Jun 30, 2019 | 3,463.00 |
| Mar 31, 2019 | 3,669.00 |
| Dec 31, 2018 | 1,674.00 |
| Mar 31, 2018 | 1,849.00 |
| Dec 31, 2017 | 4,346.00 |
| Dec 31, 2016 | -284.00 |
| Sep 30, 2016 | -1,095.00 |
| Dec 31, 2015 | 3,519.00 |
| Sep 30, 2015 | 3,197.00 |
| Jun 30, 2015 | 991.00 |
| Mar 31, 2015 | -3,948.00 |